Priority Date: 08.12.11 (GB 20110021149)

CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

  • Application ID: EP12826538
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
3 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis Vaccines and Diagnostics Srl is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 08.12.2011 - Priority Date (GB 20110021149)
  • 13.06.2013 - Publication A2 (WO2013084071)
  • 15.10.2014 - Publication A2 (EP2788022)

IPC Classification